Q2’23 revenue increased approximately 17% quarter-over-quarter to $11.3 million, and approximately 466% year-over-year; Mednow patient count increased quarter over quarter, growing by more than 9% to ~38,000 in Q2’23 versus ~35,000 in Q1’23; Adjusted EBITDA improved 32% Y/Y; Cash flow from operations improved by 7% Q/Q; achieved additional cost savings post-Q2’23 to further reduce cash … [Read more…]

HENDERSON, Nev.–(BUSINESS WIRE)–P3 Health Partners Inc. (Nasdaq: PIII), a patient-centered and physician-led population health management company (the “Company”), today announced that it has entered into definitive agreements to sell securities in a private placement with a group of institutional investors. The lead institutional investors in the private placement are affiliates of Chicago Pacific Founders (“CPF”) … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “High Potency Active Pharmaceutical Ingredients Market, by Product, by Manufacturer, by Drug, by Application, and by Region – Global Forecast to 2023-2033” report has been added to ResearchAndMarkets.com’s offering. The high potency active pharmaceutical ingredients market size is estimated to be USD 25.01 billion in 2022 and is expected to witness a CAGR … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “North America Disposable Endoscopic Procedures Count by Segments (Procedures Performed Using Disposable Laryngoscopes, Esophagoscopes, Duodenoscopes, Bronchoscopes, Ureteroscopes and Others) and Forecast, 2015-2030” report has been added to ResearchAndMarkets.com’s offering. The publisher’s report is a comprehensive databook report, covering key procedures data on the North America Disposable Endoscopic Procedures. The databook report provides procedure … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Cell-free Protein Expression Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028” report has been added to ResearchAndMarkets.com’s offering. The global cell-free protein expression market size reached US$ 246.5 Million in 2022. Looking forward, the publisher expects the market to reach US$ 323.8 Million by 2028, exhibiting a CAGR of 4.65% … [Read more…]

Lebrikizumab is a novel monoclonal antibody that binds to IL-13 with high affinity and prevents its downstream signaling with high potency The NEJM manuscript reports Week 16 efficacy and safety data from ADvocate1 and ADvocate2, two identically designed Phase 3 monotherapy studies in adults and adolescents with moderate-to-severe atopic dermatitis (AD) Lebrikizumab showed statistically significant … [Read more…]

GENT, Belgium & MALVERN, Pa. & TOKYO–(BUSINESS WIRE)–#IVD–H.U. Group Holdings Inc. and its wholly-owned subsidiary Fujirebio today announced the availability of the Lumipulse G ApoE4 and Lumipulse G Pan-ApoE assays for the fully automated LUMIPULSE® G Systems. These CLEIA (chemiluminescent enzyme immunoassay) assays allow for the quantitative measurement of the E4 isoform of the apolipoprotein … [Read more…]

Scott D. Myers to step down as Chairman end Q1 2023 MONTPELLIER, France–(BUSINESS WIRE)–Regulatory News: Sensorion (Paris:ALSEN) (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in gene therapies in the ear, announces the appointment of Khalil Barrage as Interim Chair of the Board. Mr Barrage will replace Scott D. Myers, who has informed … [Read more…]

LOS ANGELES–(BUSINESS WIRE)–AIDS Healthcare Foundation (AHF), the world’s largest provider of health care services to people living with HIV and AIDS, will be allowed to proceed with its lawsuit against Michelle Baass, Director of California’s Department of Health Care Services (DHCS), for her alleged violation of AHF’s constitutional rights. In June 2022, California abruptly cancelled … [Read more…]

TOKYO & HILVERSUM, Netherlands & OSLO, Norway & MANNHEIM, Germany–(BUSINESS WIRE)–NEC Corporation (NEC, TOKYO: 6701) announced in 2019 that it would expand the application of its cutting-edge AI technologies to drug development, focusing on advanced therapy as part of enhancing its healthcare business. Subsequently, in order to advance AI-powered personalized treatment and beyond, NEC acquired … [Read more…]